Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017 Kymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters October 29, 2017 Compugen Ltd. Provides Update On COM701 And Upcoming Presentations May 30, 2017
Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017
